Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of A Low-Carbohydrate, High-Fat, Ketogenic Diet on Obesity, Metabolic Abnormalities, and Psychiatric Symptoms on Patients With Bipolar Disorder (BPD)

NCT05705063 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT05705063
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05705063 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of A Low-Carbohydrate, High-Fat, Ketogenic Diet on Obesity, Metabolic Abnormalities, and Psychiatric Symptoms on Patients With Bipolar Disorder (BPD)
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Unknown status
Start date
January 30, 2023
Completion date
December 30, 2024
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar and related disorders, bipolar depression, bipolar disorder, bipolar disorder i, bipolar disorder, mixed, bipolar disorder, type 1, bipolar disorder, type 2, bipolar i disorder, bipolar ii disorder, brain metabolic disorder, ketogenic dieting, metabolic syndrome, obesity, psychotropic agents causing adverse effects in therapeutic use, weight gain